Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Mauri G, Patelli G, Gori V, Lauricella C, Mussolin B, Amatu A, Bencardino K, Tosi F, Bonazzina E, Bonoldi E, Bardelli A, Siena S, Sartore-Bianchi A. Mauri G, et al. Among authors: gori v. Front Oncol. 2022 Nov 7;12:1030232. doi: 10.3389/fonc.2022.1030232. eCollection 2022. Front Oncol. 2022. PMID: 36419886 Free PMC article.
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report.
Mauri G, Gori V, Patelli G, Roazzi L, Rizzetto F, De Carlis L, Mariani A, Cavallari U, Prada E, Cipani T, Aquilano MC, Bonoldi E, Vanzulli A, Siena S, Sartore-Bianchi A. Mauri G, et al. Among authors: gori v. World J Surg Oncol. 2023 Mar 31;21(1):118. doi: 10.1186/s12957-023-02976-0. World J Surg Oncol. 2023. PMID: 36998040 Free PMC article.
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Mauri G, Patelli G, Gori V, Lauricella C, Mussolin B, Amatu A, Bencardino K, Tosi F, Bonazzina E, Bonoldi E, Bardelli A, Siena S, Sartore-Bianchi A. Mauri G, et al. Among authors: gori v. Front Oncol. 2023 Mar 28;13:1147497. doi: 10.3389/fonc.2023.1147497. eCollection 2023. Front Oncol. 2023. PMID: 37056342 Free PMC article.
High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial.
Garbero E, Livigni S, Ferrari F, Finazzi S, Langer M, Malacarne P, Meca MCC, Mosca S, Olivieri C, Pozzato M, Rossi C, Tavola M, Terzitta M, Viaggi B, Bertolini G; GiViTI. Garbero E, et al. Intensive Care Med. 2021 Nov;47(11):1303-1311. doi: 10.1007/s00134-021-06501-3. Epub 2021 Oct 3. Intensive Care Med. 2021. PMID: 34601619 Clinical Trial.
A practical approach for gmp-compliant validation of real-time PCR method for mycoplasma detection in human mesenchymal stromal cells as advanced therapy medicinal product.
Becherucci V, Curini L, Ceccantini R, Bisin S, Gori V, Gentile F, De Rienzo E, Piccini L, Bindi B, Pavan P, Cunial V, Allegro E, Ermini S, Brugnolo F, Bambi F. Becherucci V, et al. Among authors: gori v. Biologicals. 2021 Sep;73:31-40. doi: 10.1016/j.biologicals.2021.07.006. Epub 2021 Aug 4. Biologicals. 2021. PMID: 34362616
101 results